Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis

(1) Background: Osteonecrosis of the femoral head (ONFH) is characterized by impaired vascularization with ischemia resulting in bone cell death, leading to the deterioration of the hip joint. Mesenchymal stem/stromal cells (MSCs) are an attractive potential therapeutic approach in this setting. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco, Juan F., Garcia-Garcia, Francisco J., Villarón, Eva M., da Casa, Carmen, Fidalgo, Helena, López-Parra, Miriam, Santos, José A., Sánchez-Guijo, Fermín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051457/
https://www.ncbi.nlm.nih.gov/pubmed/36983120
http://dx.doi.org/10.3390/jcm12062117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051457/
https://www.ncbi.nlm.nih.gov/pubmed/36983120
http://dx.doi.org/10.3390/jcm12062117

Ejemplares similares